Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ: KNSA · Real-Time Price · USD
30.26
+0.20 (0.67%)
At close: Jul 31, 2025, 4:00 PM
30.26
0.00 (0.00%)
After-hours: Jul 31, 2025, 4:10 PM EDT

Theseus Pharmaceuticals Stock Forecast

Stock Price Forecast

The 6 analysts that cover Theseus Pharmaceuticals stock have a consensus rating of "Strong Buy" and an average price target of $40.83, which forecasts a 34.93% increase in the stock price over the next year. The lowest target is $34 and the highest is $54.

Price Target: $40.83 (+34.93%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$34$40.83$40$54
Change+12.36%+34.93%+32.19%+78.45%

Analyst Ratings

The average analyst rating for Theseus Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingFeb '25Mar '25Apr '25May '25Jun '25Jul '25
Strong Buy122222
Buy444444
Hold000000
Sell000000
Strong Sell000000
Total566666

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Jefferies
Jefferies
Strong Buy
Maintains
$45$54
Strong BuyMaintains$45$54+78.45%Jul 29, 2025
Wells Fargo
Wells Fargo
Buy
Maintains
$30$42
BuyMaintains$30$42+38.80%Jul 9, 2025
Jefferies
Jefferies
Strong Buy
Maintains
$40$45
Strong BuyMaintains$40$45+48.71%Apr 29, 2025
Wedbush
Wedbush
Buy
Reiterates
$34
BuyReiterates$34+12.36%Apr 16, 2025
Citigroup
Citigroup
Strong Buy
Initiates
$40
Strong BuyInitiates$40+32.19%Mar 13, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
580.73M
from 423.24M
Increased by 37.21%
Revenue Next Year
616.15M
from 580.73M
Increased by 6.10%
EPS This Year
0.74
from -0.60
EPS Next Year
0.43
from 0.74
Decreased by -41.52%
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2025FY 2026
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2025Dec 31, 2026
Revenue
-38.54M220.18M270.26M423.24M580.73M616.15M737.01M
Revenue Growth
--471.24%22.75%56.61%37.21%6.10%19.62%
EPS
-2.61-2.302.600.20-0.600.740.430.84
EPS Growth
----92.31%---41.52%93.40%
Forward PE
-----40.9269.9736.18
No. Analysts
-----886
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026202720282029
High655.3M742.4M871.1M
Avg616.2M700.6M816.6M
Low585.1M646.6M759.5M

Revenue Growth

Revenue Growth20252026202720282029
High
54.8%
20.5%
24.3%
Avg
45.6%
13.7%
16.6%
Low
38.2%
4.9%
8.4%

EPS Forecast

EPS20252026202720282029
High1.051.602.21
Avg0.431.261.50
Low-0.230.980.82

EPS Growth

EPS Growth20252026202720282029
High-
269.8%
74.5%
Avg-
192.2%
18.7%
Low-
126.6%
-34.9%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.